These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30736330)

  • 1. TRAF6 Silencing Attenuates Multiple Myeloma Cell Adhesion to Bone Marrow Stromal Cells.
    Morgan JJ; McAvera RM; Crawford LJ
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30736330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined TRAF6 Targeting and Proteasome Blockade Has Anti-myeloma and Anti-Bone Resorptive Effects.
    Chen H; Li M; Sanchez E; Wang CS; Lee T; Soof CM; Casas CE; Cao J; Xie C; Udd KA; DeCorso K; Tang GY; Spektor TM; Berenson JR
    Mol Cancer Res; 2017 May; 15(5):598-609. PubMed ID: 28122920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
    Chen H; Li M; Campbell RA; Burkhardt K; Zhu D; Li SG; Lee HJ; Wang C; Zeng Z; Gordon MS; Bonavida B; Berenson JR
    Oncogene; 2006 Oct; 25(49):6520-7. PubMed ID: 16702955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response.
    Zheng Y; Wang Q; Li T; Qian J; Lu Y; Li Y; Bi E; Reu F; Qin Y; Drazba J; Hsi E; Yang J; Cai Z; Yi Q
    J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27381622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAF6 activation in multiple myeloma: a potential therapeutic target.
    Liu H; Tamashiro S; Baritaki S; Penichet M; Yu Y; Chen H; Berenson J; Bonavida B
    Clin Lymphoma Myeloma Leuk; 2012 Jun; 12(3):155-63. PubMed ID: 22440007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells.
    Abdi J; Rastgoo N; Chen Y; Chen GA; Chang H
    BMC Cancer; 2019 Oct; 19(1):975. PubMed ID: 31638931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma.
    Ren Z; Lantermans H; Kuil A; Kraan W; Arenzana-Seisdedos F; Kersten MJ; Spaargaren M; Pals ST
    J Hematol Oncol; 2021 Jan; 14(1):11. PubMed ID: 33436043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAZ downregulated ANXA1 expression to modulate myeloma cell interactions with bone marrow mesenchymal stromal cells.
    Abegunde SO; Grieve S; Reiman T
    Exp Hematol; 2024 Oct; 138():104282. PubMed ID: 39032857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
    Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneously Targeting Two Coupled Signalling Molecules in the Mesenchymal Stem Cell Support Efficiently Sensitises the Multiple Myeloma Cell Line H929 to Bortezomib.
    Rojas-Zambrano PM; Meyer-Herrera JE; Ruiz-Aparicio PF; Vernot JP
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of connexin-43 expression in bone marrow mesenchymal stem cells plays a crucial role in adhesion and migration of multiple myeloma cells.
    Zhang X; Sun Y; Wang Z; Huang Z; Li B; Fu J
    Leuk Lymphoma; 2015 Jan; 56(1):211-8. PubMed ID: 24724781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. siRNA-induced TRAF6 knockdown promotes the apoptosis and inhibits the invasion of human lung cancer SPC-A1 cells.
    He Z; Huang C; Lin G; Ye Y
    Oncol Rep; 2016 Apr; 35(4):1933-40. PubMed ID: 26847475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of GITR Enhances Multiple Myeloma Cell Sensitivity to Bortezomib.
    Zhao Y; Zhang K; Li G; Zhang X; Shi D
    PLoS One; 2015; 10(5):e0127334. PubMed ID: 25973846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRAF6 is required for BLyS-mediated NF-κB signaling in multiple myeloma cells.
    Wang X; Wang J; Liu H; Xu R; Ding R; Jiang S; Wang X; Huang H
    Med Oncol; 2015 Oct; 32(10):239. PubMed ID: 26334396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease.
    Garcia-Gomez A; De Las Rivas J; Ocio EM; Díaz-Rodríguez E; Montero JC; Martín M; Blanco JF; Sanchez-Guijo FM; Pandiella A; San Miguel JF; Garayoa M
    Oncotarget; 2014 Sep; 5(18):8284-305. PubMed ID: 25268740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion.
    Neri P; Ren L; Azab AK; Brentnall M; Gratton K; Klimowicz AC; Lin C; Duggan P; Tassone P; Mansoor A; Stewart DA; Boise LH; Ghobrial IM; Bahlis NJ
    Blood; 2011 Jun; 117(23):6202-13. PubMed ID: 21474670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1.
    Bar-Natan M; Stroopinsky D; Luptakova K; Coll MD; Apel A; Rajabi H; Pyzer AR; Palmer K; Reagan MR; Nahas MR; Karp Leaf R; Jain S; Arnason J; Ghobrial IM; Anderson KC; Kufe D; Rosenblatt J; Avigan D
    Br J Haematol; 2017 Mar; 176(6):929-938. PubMed ID: 28107546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signalling.
    Gupta N; Kumar R; Seth T; Garg B; Sharma A
    RNA Biol; 2020 Jan; 17(1):98-111. PubMed ID: 31532704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironment.
    Belloni D; Heltai S; Ponzoni M; Villa A; Vergani B; Pecciarini L; Marcatti M; Girlanda S; Tonon G; Ciceri F; Caligaris-Cappio F; Ferrarini M; Ferrero E
    Haematologica; 2018 Apr; 103(4):707-716. PubMed ID: 29326121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation.
    Wang X; Li C; Ju S; Wang Y; Wang H; Zhong R
    Leuk Lymphoma; 2011 Oct; 52(10):1991-8. PubMed ID: 21718132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.